Cabozantinib in Patients with Advanced Merkel Cell Carcinoma.

about

Cabozantinib in Patients with Advanced Merkel Cell Carcinoma.

Item

http://www.wikidata.org/entity/Q51751201

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Cabozantinib in Patients with Advanced Merkel Cell Carcinoma.

@en

Cabozantinib in Patients with Advanced Merkel Cell Carcinoma.

@nl

type

Item

label

Cabozantinib in Patients with Advanced Merkel Cell Carcinoma.

@en

Cabozantinib in Patients with Advanced Merkel Cell Carcinoma.

@nl

prefLabel

Cabozantinib in Patients with Advanced Merkel Cell Carcinoma.

@en

Cabozantinib in Patients with Advanced Merkel Cell Carcinoma.

@nl

P1476

Cabozantinib in Patients with Advanced Merkel Cell Carcinoma

@en

P2093

Ayushi Tyagi

http://www.w3.org/2001/XMLSchema#string

Cecilia Lezcano

http://www.w3.org/2001/XMLSchema#string

Geoffrey I Shapiro

http://www.w3.org/2001/XMLSchema#string

Hailey Becker

http://www.w3.org/2001/XMLSchema#string

James A DeCaprio

http://www.w3.org/2001/XMLSchema#string

Julian Huang

http://www.w3.org/2001/XMLSchema#string

Lynette M Sholl

http://www.w3.org/2001/XMLSchema#string

Manisha Thakuria

http://www.w3.org/2001/XMLSchema#string

Megan M Reilly

http://www.w3.org/2001/XMLSchema#string

Patricia McHugh

http://www.w3.org/2001/XMLSchema#string

P2860

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.

Invasive growth: a MET-driven genetic programme for cancer and stem cells

Merkel cell carcinoma: changing incidence trends

High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing

Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases.

Cabozantinib in progressive medullary thyroid cancer.

Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system.

Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine.

Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study.

Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors

P304

814-821

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/THEONCOLOGIST.2017-0552

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Guilherme Rabinowits

P577

2018-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29445030

http://www.w3.org/2001/XMLSchema#string

P932

6058327

http://www.w3.org/2001/XMLSchema#string